Author:
W. Swisher John,Kailash Shashank
Reference199 articles.
1. Avouac J, Airo P, Meune C, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and meta-analysis of 5 studies. The Journal of Rheumatology. 2010;37(11):2290-2298
2. Varga J, Steen V. Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, classification, risk factors, screening, and prognosis. UpToDate. 2018
3. Hao Y, Thakkar V, Stevens W, et al. A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy. 2015;17:7-18
4. Iudici M, Codullo V, Giuggioli D, et al. Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. Clinical and Experimental Rheumatology. 2013;31(Suppl 76):31-36
5. Murata I, Kihara H, Shinohara S, et al. Echocardiographic evaluation of pulmonary arterial hypertension in patients with systemic and related syndromes. Japanese Circulation Journal. 1992;56:983-991